Even when bacteria appear susceptible in routine tests, tolerance can let them survive therapy long enough to drive persistent infection, delayed clearance, and relapse.
Clinical Trials Arena on MSN
Lakewood-Amedex reports promising AMR data for Nu-3 in IDFU
Laboratory experiments exposed E. coli and MRSA to Nu-3 for 21 days. The minimum inhibitory concentration (MIC) changed in E.
Why mismatched resistance thresholds between CLSI and EUCAST could be masking the true scale of antimicrobial resistance in the environment. How can global standardization fix this problem? Study: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results